Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Aylward

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Lancet (London, England)|October 29, 2010
Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trialRoland W Sutter, T Jacob John, Hemant Jain, et al.
The Lancet. Infectious Diseases|November 11, 2011
Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trialConcepción F Estívariz, Hamid Jafari, Roland W Sutter, et al.
Lancet (London, England)|September 22, 2015
Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trialRoland W Sutter, Sunil Bahl, Jagadish M Deshpande, et al.
Science (New York, N.Y.)|August 23, 2014
Polio eradication. Efficacy of inactivated poliovirus vaccine in IndiaHamid Jafari, Jagadish M Deshpande, Roland W Sutter, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 23, 2006
Development and consideration of global policies for managing the future risks of poliovirus outbreaks: insights and lessons learned through modelingKimberly M Thompson, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
BMJ Global Health|August 24, 2025
Operationalising health in the humanitarian-development-peace nexus (HDPN) in Africa: a new framework for building resilience in countries with fragile, conflict and violence-affected settingsAmbrose Talisuna, Sohel Saikat, Redda Seifeldin, et al.
Lancet (London, England)|March 3, 2024
Confronting the elephants in the room: reigniting momentum for universal health coverageKatri Bertram, Bruce Aylward, Laetitia Bosio, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 13, 2016
Ebola Virus Persistence in Breast Milk After No Reported Illness: A Likely Source of Virus Transmission From Mother to ChildDaouda Sissoko, Mory Keïta, Boubacar Diallo, et al.
Frontiers in Public Health|March 18, 2017
Epidemiology of Ebola Virus Disease in the Western Area Region of Sierra Leone, 2014-2015Margaret Lamunu, Olushayo Oluseun Olu, James Bangura, et al.
BMJ Global Health|October 9, 2020
Systems thinking for health emergencies: use of process mapping during outbreak responseKara N Durski, Dhamari Naidoo, Shalini Singaravelu, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Lancet (London, England)|October 29, 2010
Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trialRoland W Sutter, T Jacob John, Hemant Jain, et al.
The Lancet. Infectious Diseases|November 11, 2011
Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trialConcepción F Estívariz, Hamid Jafari, Roland W Sutter, et al.
Lancet (London, England)|September 22, 2015
Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trialRoland W Sutter, Sunil Bahl, Jagadish M Deshpande, et al.
Science (New York, N.Y.)|August 23, 2014
Polio eradication. Efficacy of inactivated poliovirus vaccine in IndiaHamid Jafari, Jagadish M Deshpande, Roland W Sutter, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 23, 2006
Development and consideration of global policies for managing the future risks of poliovirus outbreaks: insights and lessons learned through modelingKimberly M Thompson, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
BMJ Global Health|August 24, 2025
Operationalising health in the humanitarian-development-peace nexus (HDPN) in Africa: a new framework for building resilience in countries with fragile, conflict and violence-affected settingsAmbrose Talisuna, Sohel Saikat, Redda Seifeldin, et al.
Lancet (London, England)|March 3, 2024
Confronting the elephants in the room: reigniting momentum for universal health coverageKatri Bertram, Bruce Aylward, Laetitia Bosio, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 13, 2016
Ebola Virus Persistence in Breast Milk After No Reported Illness: A Likely Source of Virus Transmission From Mother to ChildDaouda Sissoko, Mory Keïta, Boubacar Diallo, et al.
Frontiers in Public Health|March 18, 2017
Epidemiology of Ebola Virus Disease in the Western Area Region of Sierra Leone, 2014-2015Margaret Lamunu, Olushayo Oluseun Olu, James Bangura, et al.
BMJ Global Health|October 9, 2020
Systems thinking for health emergencies: use of process mapping during outbreak responseKara N Durski, Dhamari Naidoo, Shalini Singaravelu, et al.
Pageof 7